Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis

NCT00164008 is registered in ClinicalTrials.gov with Bayside Health as lead sponsor.

NCT NCT00164008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00164008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison Between Pamidronate and Zoledronic Acid for the Treatment of Heart and Lung Transplant Related Osteopaenia and Osteoporosis
Lead sponsor
Bayside Health
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2002
Completion date
December 31, 2005
Enrollment
56 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

complications of heart-lung transplant, osteopenia, other complications of lung transplant